[HTML][HTML] The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer

WH Hsu, BW Shiau, YW Tsai, JY Wu, PY Huang… - Journal of Infection and …, 2024 - Elsevier
Backgrounds The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …

Breaking through the noise: how to unveil the cognitive impact of long COVID on pre-existing conditions with executive dysfunctions?

C Jose - Frontiers in Psychiatry, 2024 - frontiersin.org
I am a Canadian patient-oriented researcher working with patient partners with cognitive
disorders [notably, autism, learning disorders, and attention deficit/hyperactivity disorders …

Secuelas neurológicas post-covid en pacientes pediátricos

JN García García - REPOSITORIO NACIONAL CONACYT, 2024 - ninive.uaslp.mx
El coronavirus (SARS-CoV-2) es un virus que surgió a finales del 2019, siendo la causa de
una pandemia mundial de la enfermedad denominada como “Enfermedad por Coronavirus …